|
|
cellular amino acid metabolic process
|
GO:0006520 |
103 |
0.305
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.278
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
66 |
0.277
|
|
|
|
cell junction organization
|
GO:0034330 |
77 |
0.257
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
178 |
0.243
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
44 |
0.235
|
|
|
|
negative regulation of synapse assembly
|
GO:0051964 |
3 |
0.230
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
203 |
0.216
|
|
|
|
leukocyte differentiation
|
GO:0002521 |
342 |
0.207
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
20 |
0.202
|
|
|
|
establishment or maintenance of microtubule cytoskeleton polarity
|
GO:0030951 |
1 |
0.198
|
|
|
|
renal system process
|
GO:0003014 |
48 |
0.190
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
162 |
0.189
|
|
|
|
placenta development
|
GO:0001890 |
140 |
0.173
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
306 |
0.164
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
361 |
0.163
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
5 |
0.154
|
|
|
|
skeletal system development
|
GO:0001501 |
356 |
0.148
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
220 |
0.144
|
|
|
|
organonitrogen compound catabolic process
|
GO:1901565 |
264 |
0.138
|
|
|
|
oxidation reduction process
|
GO:0055114 |
342 |
0.138
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
159 |
0.130
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
54 |
0.130
|
|
|
|
carbohydrate derivative catabolic process
|
GO:1901136 |
231 |
0.130
|
|
|
|
epidermis development
|
GO:0008544 |
187 |
0.125
|
|
|
|
glycosyl compound metabolic process
|
GO:1901657 |
246 |
0.125
|
|
|
|
nucleoside phosphate metabolic process
|
GO:0006753 |
338 |
0.124
|
|
|
|
multicellular organismal homeostasis
|
GO:0048871 |
164 |
0.117
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
82 |
0.117
|
|
|
|
cytokine mediated signaling pathway
|
GO:0019221 |
115 |
0.115
|
|
|
|
cell cell junction organization
|
GO:0045216 |
72 |
0.111
|
|
|
|
transmembrane transport
|
GO:0055085 |
412 |
0.111
|
|
|
|
negative regulation of growth
|
GO:0045926 |
99 |
0.111
|
|
|
|
epithelial cell development
|
GO:0002064 |
159 |
0.111
|
|
|
|
cell division
|
GO:0051301 |
120 |
0.107
|
|
|
|
telencephalon development
|
GO:0021537 |
186 |
0.107
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
96 |
0.104
|
|
|
|
protein targeting
|
GO:0006605 |
143 |
0.103
|
|
|
|
cell growth
|
GO:0016049 |
130 |
0.102
|
|
|
|
gland development
|
GO:0048732 |
330 |
0.101
|
|
|
|
regulation of protein transport
|
GO:0051223 |
163 |
0.099
|
|
|
|
regulation of secretion
|
GO:0051046 |
274 |
0.096
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
323 |
0.096
|
|
|
|
protein localization to plasma membrane
|
GO:0072659 |
57 |
0.095
|
|
|
|
amine metabolic process
|
GO:0009308 |
45 |
0.095
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
189 |
0.094
|
|
|
|
regulation of cell growth
|
GO:0001558 |
91 |
0.092
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
84 |
0.091
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
249 |
0.091
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
206 |
0.089
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
198 |
0.089
|
|
|
|
purine containing compound metabolic process
|
GO:0072521 |
311 |
0.089
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
208 |
0.088
|
|
|
|
regulation of organelle organization
|
GO:0033043 |
289 |
0.088
|
|
|
|
skin development
|
GO:0043588 |
220 |
0.088
|
|
|
|
nephric duct formation
|
GO:0072179 |
4 |
0.087
|
|
|
|
hair follicle development
|
GO:0001942 |
85 |
0.087
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
169 |
0.085
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
181 |
0.084
|
|
|
|
nucleobase containing small molecule metabolic process
|
GO:0055086 |
352 |
0.084
|
|
|
|
ribonucleoside metabolic process
|
GO:0009119 |
245 |
0.084
|
|
|
|
lipid biosynthetic process
|
GO:0008610 |
179 |
0.084
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
296 |
0.083
|
|
|
|
brown fat cell differentiation
|
GO:0050873 |
36 |
0.082
|
|
|
|
neuronal action potential
|
GO:0019228 |
54 |
0.082
|
|
|
|
sensory perception
|
GO:0007600 |
245 |
0.082
|
|
|
|
transmembrane receptor protein tyrosine kinase signaling pathway
|
GO:0007169 |
247 |
0.081
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
5 |
0.081
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
213 |
0.079
|
|
|
|
stem cell differentiation
|
GO:0048863 |
268 |
0.079
|
|
|
|
cation homeostasis
|
GO:0055080 |
212 |
0.078
|
|
|
|
alpha beta t cell activation
|
GO:0046631 |
91 |
0.078
|
|
|
|
synaptic transmission
|
GO:0007268 |
329 |
0.078
|
|
|
|
cellular response to inorganic substance
|
GO:0071241 |
37 |
0.077
|
|
|
|
g protein coupled receptor signaling pathway
|
GO:0007186 |
243 |
0.077
|
|
|
|
regulation of hydrolase activity
|
GO:0051336 |
246 |
0.076
|
|
|
|
cellular calcium ion homeostasis
|
GO:0006874 |
119 |
0.075
|
|
|
|
nucleoside metabolic process
|
GO:0009116 |
246 |
0.075
|
|
|
|
endomembrane system organization
|
GO:0010256 |
147 |
0.075
|
|
|
|
mesonephric duct formation
|
GO:0072181 |
2 |
0.074
|
|
|
|
negative regulation of immune system process
|
GO:0002683 |
209 |
0.074
|
|
|
|
regulation of transforming growth factor beta2 production
|
GO:0032909 |
2 |
0.073
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
48 |
0.071
|
|
|
|
forebrain development
|
GO:0030900 |
302 |
0.071
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
263 |
0.071
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
241 |
0.071
|
|
|
|
ameboidal type cell migration
|
GO:0001667 |
128 |
0.070
|
|
|
|
regulation of hormone levels
|
GO:0010817 |
211 |
0.070
|
|
|
|
intracellular protein transport
|
GO:0006886 |
204 |
0.070
|
|
|
|
regulation of alpha beta t cell activation
|
GO:0046634 |
53 |
0.069
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
130 |
0.068
|
|
|
|
wound healing
|
GO:0042060 |
157 |
0.068
|
|
|
|
methylation
|
GO:0032259 |
134 |
0.067
|
|
|
|
protein processing
|
GO:0016485 |
163 |
0.067
|
|
|
|
developmental maturation
|
GO:0021700 |
193 |
0.067
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
114 |
0.066
|
|
|
|
nucleotide metabolic process
|
GO:0009117 |
332 |
0.065
|
|
|
|
positive regulation of protein modification process
|
GO:0031401 |
299 |
0.065
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
205 |
0.064
|
|
|
|
epithelial tube morphogenesis
|
GO:0060562 |
303 |
0.064
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
97 |
0.064
|
|
|
|
neural tube development
|
GO:0021915 |
160 |
0.063
|
|
|
|
purine nucleotide metabolic process
|
GO:0006163 |
302 |
0.062
|
|
|
|
regionalization
|
GO:0003002 |
337 |
0.062
|
|
|
|
protein localization to membrane
|
GO:0072657 |
108 |
0.062
|
|
|
|
fat cell differentiation
|
GO:0045444 |
160 |
0.061
|
|
|
|
regulation of protein localization
|
GO:0032880 |
231 |
0.059
|
|
|
|
positive regulation of gtpase activity
|
GO:0043547 |
85 |
0.059
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
208 |
0.059
|
|
|
|
generation of precursor metabolites and energy
|
GO:0006091 |
103 |
0.059
|
|
|
|
regulation of gtp catabolic process
|
GO:0033124 |
113 |
0.058
|
|
|
|
aromatic compound catabolic process
|
GO:0019439 |
286 |
0.058
|
|
|
|
fertilization
|
GO:0009566 |
127 |
0.057
|
|
|
|
response to oxidative stress
|
GO:0006979 |
123 |
0.057
|
|
|
|
negative regulation of cell migration
|
GO:0030336 |
59 |
0.057
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
268 |
0.057
|
|
|
|
regulation of renal sodium excretion
|
GO:0035813 |
3 |
0.056
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
144 |
0.056
|
|
|
|
response to radiation
|
GO:0009314 |
165 |
0.056
|
|
|
|
rho protein signal transduction
|
GO:0007266 |
32 |
0.056
|
|
|
|
regulation of membrane potential
|
GO:0042391 |
192 |
0.055
|
|
|
|
monocarboxylic acid metabolic process
|
GO:0032787 |
191 |
0.055
|
|
|
|
cd4 positive alpha beta t cell activation
|
GO:0035710 |
45 |
0.055
|
|
|
|
hair cycle
|
GO:0042633 |
90 |
0.055
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
220 |
0.054
|
|
|
|
mesonephric duct morphogenesis
|
GO:0072180 |
4 |
0.054
|
|
|
|
pallium development
|
GO:0021543 |
120 |
0.054
|
|
|
|
compound eye development
|
GO:0048749 |
1 |
0.053
|
|
|
|
synapse organization
|
GO:0050808 |
125 |
0.053
|
|
|
|
positive regulation of anagen
|
GO:0051885 |
1 |
0.053
|
|
|
|
hippocampus development
|
GO:0021766 |
52 |
0.053
|
|
|
|
regulation of system process
|
GO:0044057 |
200 |
0.053
|
|
|
|
organophosphate biosynthetic process
|
GO:0090407 |
122 |
0.053
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
77 |
0.053
|
|
|
|
retinal blood vessel morphogenesis
|
GO:0061304 |
3 |
0.052
|
|
|
|
molting cycle
|
GO:0042303 |
90 |
0.051
|
|
|
|
cation transmembrane transport
|
GO:0098655 |
266 |
0.051
|
|
|
|
protein secretion
|
GO:0009306 |
111 |
0.051
|
|
|
|
inner ear morphogenesis
|
GO:0042472 |
101 |
0.051
|
|
|
|
spermatogenesis
|
GO:0007283 |
284 |
0.051
|
|
|
|
androgen biosynthetic process
|
GO:0006702 |
4 |
0.051
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
159 |
0.051
|
|
|
|
cofactor transport
|
GO:0051181 |
4 |
0.050
|
|
|
|
protein maturation
|
GO:0051604 |
176 |
0.050
|
|
|
|
cell fate commitment
|
GO:0045165 |
210 |
0.050
|
|
|
|
male gamete generation
|
GO:0048232 |
285 |
0.050
|
|
|
|
negative regulation of hydrolase activity
|
GO:0051346 |
71 |
0.050
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
293 |
0.050
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
249 |
0.049
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
139 |
0.048
|
|
|
|
positive regulation of growth
|
GO:0045927 |
104 |
0.048
|
|
|
|
regulation of testosterone biosynthetic process
|
GO:2000224 |
2 |
0.048
|
|
|
|
lymphocyte activation involved in immune response
|
GO:0002285 |
93 |
0.048
|
|
|
|
purine ribonucleotide metabolic process
|
GO:0009150 |
290 |
0.048
|
|
|
|
locomotory behavior
|
GO:0007626 |
195 |
0.048
|
|
|
|
pigment granule localization
|
GO:0051875 |
13 |
0.047
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
29 |
0.047
|
|
|
|
heterocycle catabolic process
|
GO:0046700 |
280 |
0.047
|
|
|
|
renal sodium excretion
|
GO:0035812 |
3 |
0.047
|
|
|
|
regulation of cd4 positive alpha beta t cell activation
|
GO:2000514 |
24 |
0.047
|
|
|
|
neural tube formation
|
GO:0001841 |
108 |
0.046
|
|
|
|
alpha amino acid metabolic process
|
GO:1901605 |
59 |
0.046
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
169 |
0.046
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
217 |
0.046
|
|
|
|
negative regulation of molecular function
|
GO:0044092 |
258 |
0.046
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
203 |
0.046
|
|
|
|
germ cell development
|
GO:0007281 |
185 |
0.045
|
|
|
|
ubiquitin dependent smad protein catabolic process
|
GO:0030579 |
2 |
0.045
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
205 |
0.045
|
|
|
|
fatty acid metabolic process
|
GO:0006631 |
121 |
0.044
|
|
|
|
regulation of leukocyte differentiation
|
GO:1902105 |
159 |
0.044
|
|
|
|
negative regulation of cell motility
|
GO:2000146 |
61 |
0.044
|
|
|
|
atrial ventricular junction remodeling
|
GO:0003294 |
2 |
0.043
|
|
|
|
regulation of cell division
|
GO:0051302 |
76 |
0.043
|
|
|
|
positive regulation of purine nucleotide metabolic process
|
GO:1900544 |
114 |
0.043
|
|
|
|
dephosphorylation
|
GO:0016311 |
129 |
0.043
|
|
|
|
positive regulation of hair cycle
|
GO:0042635 |
7 |
0.043
|
|
|
|
non canonical wnt signaling pathway via jnk cascade
|
GO:0038031 |
3 |
0.043
|
|
|
|
mesonephric epithelium development
|
GO:0072163 |
94 |
0.043
|
|
|
|
organic cyclic compound catabolic process
|
GO:1901361 |
295 |
0.042
|
|
|
|
tissue regeneration
|
GO:0042246 |
22 |
0.042
|
|
|
|
retrograde transport endosome to golgi
|
GO:0042147 |
2 |
0.042
|
|
|
|
viral process
|
GO:0016032 |
41 |
0.042
|
|
|
|
axon ensheathment
|
GO:0008366 |
76 |
0.042
|
|
|
|
regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000079 |
1 |
0.042
|
|
|
|
oxygen homeostasis
|
GO:0032364 |
2 |
0.041
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
184 |
0.041
|
|
|
|
regulation of endopeptidase activity
|
GO:0052548 |
89 |
0.041
|
|
|
|
positive regulation of canonical wnt signaling pathway involved in controlling type b pancreatic cell proliferation
|
GO:2000081 |
1 |
0.041
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
222 |
0.041
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
205 |
0.040
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
206 |
0.040
|
|
|
|
regulation of mapk cascade
|
GO:0043408 |
248 |
0.040
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
128 |
0.040
|
|
|
|
mapk cascade
|
GO:0000165 |
281 |
0.040
|
|
|
|
nuclear transport
|
GO:0051169 |
139 |
0.040
|
|
|
|
myeloid leukocyte differentiation
|
GO:0002573 |
119 |
0.040
|
|
|
|
gas homeostasis
|
GO:0033483 |
3 |
0.040
|
|
|
|
renal vesicle induction
|
GO:0072034 |
3 |
0.040
|
|
|
|
negative regulation of leukocyte differentiation
|
GO:1902106 |
51 |
0.039
|
|
|
|
germ line stem cell division
|
GO:0042078 |
2 |
0.039
|
|
|
|
positive regulation of cell morphogenesis involved in differentiation
|
GO:0010770 |
72 |
0.039
|
|
|
|
regulation of cell size
|
GO:0008361 |
72 |
0.039
|
|
|
|
myoblast differentiation involved in skeletal muscle regeneration
|
GO:0014835 |
3 |
0.038
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
157 |
0.038
|
|
|
|
response to inorganic substance
|
GO:0010035 |
96 |
0.038
|
|
|
|
protein citrullination
|
GO:0018101 |
2 |
0.038
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
247 |
0.038
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
206 |
0.038
|
|
|
|
endocrine system development
|
GO:0035270 |
98 |
0.038
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
218 |
0.038
|
|
|
|
inclusion body assembly
|
GO:0070841 |
3 |
0.038
|
|
|
|
regulation of wnt signaling pathway
|
GO:0030111 |
123 |
0.038
|
|
|
|
renal inner medulla development
|
GO:0072053 |
3 |
0.038
|
|
|
|
regulation of cell activation
|
GO:0050865 |
289 |
0.038
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
130 |
0.038
|
|
|
|
regulation of response to wounding
|
GO:1903034 |
189 |
0.037
|
|
|
|
small molecule biosynthetic process
|
GO:0044283 |
132 |
0.037
|
|
|
|
organelle localization
|
GO:0051640 |
179 |
0.037
|
|
|
|
energy derivation by oxidation of organic compounds
|
GO:0015980 |
77 |
0.037
|
|
|
|
positive regulation of purine nucleotide catabolic process
|
GO:0033123 |
88 |
0.037
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
199 |
0.037
|
|
|
|
positive regulation of cell growth
|
GO:0030307 |
33 |
0.036
|
|
|
|
steroid biosynthetic process
|
GO:0006694 |
47 |
0.036
|
|
|
|
ossification
|
GO:0001503 |
216 |
0.036
|
|
|
|
stem cell development
|
GO:0048864 |
219 |
0.036
|
|
|
|
regulation of cell shape
|
GO:0008360 |
39 |
0.036
|
|
|
|
platelet activation
|
GO:0030168 |
40 |
0.036
|
|
|
|
ribose phosphate metabolic process
|
GO:0019693 |
291 |
0.036
|
|
|
|
defecation
|
GO:0030421 |
1 |
0.036
|
|
|
|
protein localization to organelle
|
GO:0033365 |
185 |
0.036
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
148 |
0.035
|
|
|
|
ear development
|
GO:0043583 |
200 |
0.035
|
|
|
|
alpha beta t cell differentiation
|
GO:0046632 |
69 |
0.035
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
226 |
0.035
|
|
|
|
skeletal muscle tissue regeneration
|
GO:0043403 |
20 |
0.035
|
|
|
|
establishment of planar polarity involved in nephron morphogenesis
|
GO:0072046 |
1 |
0.035
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
282 |
0.035
|
|
|
|
ribonucleotide metabolic process
|
GO:0009259 |
291 |
0.035
|
|
|
|
cellular chemical homeostasis
|
GO:0055082 |
215 |
0.035
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
242 |
0.035
|
|
|
|
cellular response to calcium ion
|
GO:0071277 |
14 |
0.035
|
|
|
|
organic hydroxy compound biosynthetic process
|
GO:1901617 |
77 |
0.035
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
234 |
0.034
|
|
|
|
establishment of protein localization to organelle
|
GO:0072594 |
118 |
0.034
|
|
|
|
inflammatory response
|
GO:0006954 |
244 |
0.034
|
|
|
|
regulation of nucleotide catabolic process
|
GO:0030811 |
122 |
0.034
|
|
|
|
hormone secretion
|
GO:0046879 |
128 |
0.034
|
|
|
|
purine containing compound biosynthetic process
|
GO:0072522 |
70 |
0.034
|
|
|
|
carbohydrate metabolic process
|
GO:0005975 |
230 |
0.034
|
|
|
|
negative regulation of intracellular signal transduction
|
GO:1902532 |
167 |
0.034
|
|
|
|
tertiary branching involved in mammary gland duct morphogenesis
|
GO:0060748 |
3 |
0.034
|
|
|
|
regulation of lipid metabolic process
|
GO:0019216 |
118 |
0.034
|
|
|
|
cellular nitrogen compound catabolic process
|
GO:0044270 |
280 |
0.033
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
211 |
0.033
|
|
|
|
amide transport
|
GO:0042886 |
138 |
0.033
|
|
|
|
cytokine production
|
GO:0001816 |
319 |
0.033
|
|
|
|
positive regulation of ras gtpase activity
|
GO:0032320 |
65 |
0.033
|
|
|
|
regeneration
|
GO:0031099 |
38 |
0.033
|
|
|
|
oocyte construction
|
GO:0007308 |
2 |
0.033
|
|
|
|
lymphocyte differentiation
|
GO:0030098 |
242 |
0.033
|
|
|
|
regulation of ion transmembrane transport
|
GO:0034765 |
119 |
0.033
|
|
|
|
neuroblast differentiation
|
GO:0014016 |
2 |
0.033
|
|
|
|
macromolecule methylation
|
GO:0043414 |
120 |
0.033
|
|
|
|
calcium ion transmembrane transport
|
GO:0070588 |
85 |
0.033
|
|
|
|
plasma membrane organization
|
GO:0007009 |
90 |
0.033
|
|
|
|
cellular homeostasis
|
GO:0019725 |
240 |
0.032
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
164 |
0.032
|
|
|
|
cation transport
|
GO:0006812 |
399 |
0.032
|
|
|
|
anatomical structure maturation
|
GO:0071695 |
49 |
0.032
|
|
|
|
negative regulation of epithelial cell proliferation
|
GO:0050680 |
64 |
0.032
|
|
|
|
response to molecule of bacterial origin
|
GO:0002237 |
143 |
0.032
|
|
|
|
ear morphogenesis
|
GO:0042471 |
118 |
0.032
|
|
|
|
phenol containing compound metabolic process
|
GO:0018958 |
60 |
0.032
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
87 |
0.032
|
|
|
|
protein alkylation
|
GO:0008213 |
81 |
0.031
|
|
|
|
embryonic organ morphogenesis
|
GO:0048562 |
276 |
0.031
|
|
|
|
negative regulation of cell size
|
GO:0045792 |
3 |
0.031
|
|
|
|
peptidyl amino acid modification
|
GO:0018193 |
336 |
0.031
|
|
|
|
primary neural tube formation
|
GO:0014020 |
95 |
0.031
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
85 |
0.031
|
|
|
|
steroid metabolic process
|
GO:0008202 |
119 |
0.031
|
|
|
|
columnar cuboidal epithelial cell differentiation
|
GO:0002065 |
82 |
0.031
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
114 |
0.031
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
163 |
0.031
|
|
|
|
establishment of melanosome localization
|
GO:0032401 |
11 |
0.031
|
|
|
|
organic hydroxy compound transport
|
GO:0015850 |
93 |
0.031
|
|
|
|
detection of mechanical stimulus involved in sensory perception of pain
|
GO:0050966 |
4 |
0.031
|
|
|
|
purine nucleoside metabolic process
|
GO:0042278 |
241 |
0.031
|
|
|
|
cd4 positive alpha beta t cell differentiation
|
GO:0043367 |
41 |
0.031
|
|
|
|
t cell activation
|
GO:0042110 |
289 |
0.031
|
|
|
|
limb development
|
GO:0060173 |
166 |
0.030
|
|
|
|
positive regulation of epithelial cell proliferation involved in lung morphogenesis
|
GO:0060501 |
3 |
0.030
|
|
|
|
negative regulation of defense response
|
GO:0031348 |
77 |
0.030
|
|
|
|
positive regulation of cell development
|
GO:0010720 |
237 |
0.030
|
|
|
|
peptide secretion
|
GO:0002790 |
114 |
0.030
|
|
|
|
negative regulation of endopeptidase activity
|
GO:0010951 |
44 |
0.030
|
|
|
|
gtp catabolic process
|
GO:0006184 |
143 |
0.030
|
|
|
|
positive regulation of nucleotide catabolic process
|
GO:0030813 |
88 |
0.030
|
|
|
|
regulation of rho protein signal transduction
|
GO:0035023 |
71 |
0.030
|
|
|
|
lymphocyte proliferation
|
GO:0046651 |
164 |
0.030
|
|
|
|
regulation of rho gtpase activity
|
GO:0032319 |
58 |
0.030
|
|
|
|
epithelium migration
|
GO:0090132 |
63 |
0.029
|
|
|
|
oocyte axis specification
|
GO:0007309 |
2 |
0.029
|
|
|
|
guanosine containing compound catabolic process
|
GO:1901069 |
144 |
0.029
|
|
|
|
peptide hormone secretion
|
GO:0030072 |
109 |
0.029
|
|
|
|
excretion
|
GO:0007588 |
22 |
0.029
|
|
|
|
non canonical wnt signaling pathway via mapk cascade
|
GO:0038030 |
3 |
0.029
|
|
|
|
organic acid biosynthetic process
|
GO:0016053 |
86 |
0.028
|
|
|
|
hematopoietic progenitor cell differentiation
|
GO:0002244 |
143 |
0.028
|
|
|
|
reflex
|
GO:0060004 |
22 |
0.028
|
|
|
|
canonical wnt signaling pathway involved in regulation of type b pancreatic cell proliferation
|
GO:0044343 |
1 |
0.028
|
|
|
|
cell junction maintenance
|
GO:0034331 |
4 |
0.028
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
163 |
0.028
|
|
|
|
midgut development
|
GO:0007494 |
4 |
0.028
|
|
|
|
renal tubule morphogenesis
|
GO:0061333 |
72 |
0.028
|
|
|
|
planar cell polarity pathway involved in pericardium morphogenesis
|
GO:0061354 |
2 |
0.028
|
|
|
|
camera type eye development
|
GO:0043010 |
266 |
0.028
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
199 |
0.028
|
|
|
|
tube formation
|
GO:0035148 |
140 |
0.028
|
|
|
|
spemann organizer formation at the anterior end of the primitive streak
|
GO:0060064 |
1 |
0.027
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
197 |
0.027
|
|
|
|
extrinsic apoptotic signaling pathway
|
GO:0097191 |
126 |
0.027
|
|
|
|
limbic system development
|
GO:0021761 |
72 |
0.027
|
|
|
|
positive regulation of cell projection organization
|
GO:0031346 |
95 |
0.027
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
127 |
0.027
|
|
|
|
regulation of neuron death
|
GO:1901214 |
134 |
0.027
|
|
|
|
cop9 signalosome assembly
|
GO:0010387 |
2 |
0.027
|
|
|
|
neuron death
|
GO:0070997 |
154 |
0.027
|
|
|
|
spongiotrophoblast layer development
|
GO:0060712 |
15 |
0.027
|
|
|
|
sensory perception of chemical stimulus
|
GO:0007606 |
51 |
0.027
|
|
|
|
g protein coupled acetylcholine receptor signaling pathway
|
GO:0007213 |
4 |
0.027
|
|
|
|
closure of optic fissure
|
GO:0061386 |
2 |
0.027
|
|
|
|
purine nucleotide biosynthetic process
|
GO:0006164 |
65 |
0.027
|
|
|
|
chondrocyte hypertrophy
|
GO:0003415 |
4 |
0.027
|
|
|
|
labyrinthine layer development
|
GO:0060711 |
49 |
0.027
|
|
|
|
central nervous system neuron differentiation
|
GO:0021953 |
162 |
0.027
|
|
|
|
regulation of transmembrane transport
|
GO:0034762 |
128 |
0.027
|
|
|
|
cellular response to lipid
|
GO:0071396 |
145 |
0.027
|
|
|
|
positive regulation of rho gtpase activity
|
GO:0032321 |
41 |
0.026
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
74 |
0.026
|
|
|
|
inner medullary collecting duct development
|
GO:0072061 |
2 |
0.026
|
|
|
|
camp biosynthetic process
|
GO:0006171 |
31 |
0.026
|
|
|
|
septum primum development
|
GO:0003284 |
4 |
0.026
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
203 |
0.026
|
|
|
|
regulation of neurotransmitter levels
|
GO:0001505 |
87 |
0.026
|
|
|
|
regulation of asymmetric cell division
|
GO:0009786 |
4 |
0.026
|
|
|
|
lung induction
|
GO:0060492 |
3 |
0.026
|
|
|
|
circadian regulation of gene expression
|
GO:0032922 |
48 |
0.026
|
|
|
|
histone lysine methylation
|
GO:0034968 |
50 |
0.026
|
|
|
|
placenta blood vessel development
|
GO:0060674 |
31 |
0.026
|
|
|
|
t cell differentiation
|
GO:0030217 |
174 |
0.026
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
122 |
0.026
|
|
|
|
regulation of cytokine production
|
GO:0001817 |
266 |
0.026
|
|
|
|
appendage development
|
GO:0048736 |
166 |
0.025
|
|
|
|
regulation of neuron differentiation
|
GO:0045664 |
281 |
0.025
|
|
|
|
membrane organization
|
GO:0061024 |
245 |
0.025
|
|
|
|
keratinization
|
GO:0031424 |
9 |
0.025
|
|
|
|
central nervous system morphogenesis
|
GO:0021551 |
2 |
0.025
|
|
|
|
regulation of cell cell adhesion mediated by cadherin
|
GO:2000047 |
2 |
0.025
|
|
|
|
interleukin 13 secretion
|
GO:0072611 |
2 |
0.025
|
|
|
|
regulation of cyclic nucleotide metabolic process
|
GO:0030799 |
40 |
0.025
|
|
|
|
response to metal ion
|
GO:0010038 |
47 |
0.025
|
|
|
|
alcohol biosynthetic process
|
GO:0046165 |
43 |
0.025
|
|
|
|
regulation of cellular component size
|
GO:0032535 |
121 |
0.025
|
|
|
|
positive regulation of nucleoside metabolic process
|
GO:0045979 |
91 |
0.025
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
220 |
0.025
|
|
|
|
ribose phosphate biosynthetic process
|
GO:0046390 |
59 |
0.025
|
|
|
|
epithelial tube formation
|
GO:0072175 |
130 |
0.025
|
|
|
|
regulation of fat cell differentiation
|
GO:0045598 |
81 |
0.024
|
|
|
|
cellular carbohydrate metabolic process
|
GO:0044262 |
119 |
0.024
|
|
|
|
intrinsic apoptotic signaling pathway in response to oxidative stress
|
GO:0008631 |
19 |
0.024
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
230 |
0.024
|
|
|
|
positive regulation of insulin receptor signaling pathway
|
GO:0046628 |
4 |
0.024
|
|
|
|
oogenesis
|
GO:0048477 |
56 |
0.024
|
|
|
|
gtp metabolic process
|
GO:0046039 |
144 |
0.024
|
|
|
|
positive regulation of mammary gland involution
|
GO:1903521 |
4 |
0.024
|
|
|
|
positive regulation of actin filament bundle assembly
|
GO:0032233 |
11 |
0.024
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
194 |
0.024
|
|
|
|
sensory organ morphogenesis
|
GO:0090596 |
242 |
0.024
|
|
|
|
cellular polysaccharide metabolic process
|
GO:0044264 |
38 |
0.024
|
|
|
|
regulation of glutamate metabolic process
|
GO:2000211 |
1 |
0.024
|
|
|
|
regulation of cell migration
|
GO:0030334 |
219 |
0.024
|
|
|
|
divalent inorganic cation transport
|
GO:0072511 |
178 |
0.024
|
|
|
|
cardiac septum development
|
GO:0003279 |
59 |
0.023
|
|
|
|
regulation of mesenchymal cell apoptotic process involved in nephron morphogenesis
|
GO:0072039 |
4 |
0.023
|
|
|
|
actin filament bundle assembly
|
GO:0051017 |
40 |
0.023
|
|
|
|
embryonic digit morphogenesis
|
GO:0042733 |
56 |
0.023
|
|
|
|
skeletal muscle organ development
|
GO:0060538 |
163 |
0.023
|
|
|
|
regulation of generation of precursor metabolites and energy
|
GO:0043467 |
38 |
0.023
|
|
|
|
transforming growth factor beta2 production
|
GO:0032906 |
2 |
0.023
|
|
|
|
heart morphogenesis
|
GO:0003007 |
178 |
0.023
|
|
|
|
cell maturation
|
GO:0048469 |
127 |
0.023
|
|
|
|
endocytosis
|
GO:0006897 |
168 |
0.023
|
|
|
|
learning
|
GO:0007612 |
98 |
0.023
|
|
|
|
negative regulation of inflammatory response
|
GO:0050728 |
61 |
0.023
|
|
|
|
respiratory system development
|
GO:0060541 |
190 |
0.023
|
|
|
|
regulation of anagen
|
GO:0051884 |
1 |
0.023
|
|
|
|
dendrite development
|
GO:0016358 |
115 |
0.023
|
|
|
|
establishment or maintenance of cytoskeleton polarity
|
GO:0030952 |
2 |
0.023
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
160 |
0.023
|
|
|
|
regulation of actin cytoskeleton organization
|
GO:0032956 |
84 |
0.023
|
|
|
|
blood coagulation
|
GO:0007596 |
76 |
0.023
|
|
|
|
skin morphogenesis
|
GO:0043589 |
38 |
0.023
|
|
|
|
positive regulation of apoptotic process involved in mammary gland involution
|
GO:0060058 |
4 |
0.023
|
|
|
|
lung field specification
|
GO:0060424 |
3 |
0.023
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
73 |
0.023
|
|
|
|
regulation of alpha beta t cell differentiation
|
GO:0046637 |
35 |
0.023
|
|
|
|
skeletal system morphogenesis
|
GO:0048705 |
203 |
0.023
|
|
|
|
maintenance of cell number
|
GO:0098727 |
3 |
0.023
|
|
|
|
embryonic placenta development
|
GO:0001892 |
98 |
0.022
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
145 |
0.022
|
|
|
|
positive regulation of jun kinase activity
|
GO:0043507 |
30 |
0.022
|
|
|
|
epithelial cell migration
|
GO:0010631 |
63 |
0.022
|
|
|
|
glial cell apoptotic process
|
GO:0034349 |
3 |
0.022
|
|
|
|
hindbrain formation
|
GO:0021576 |
1 |
0.022
|
|
|
|
feeding behavior
|
GO:0007631 |
62 |
0.022
|
|
|
|
regulation of jnk cascade
|
GO:0046328 |
62 |
0.022
|
|
|
|
planar cell polarity pathway involved in outflow tract morphogenesis
|
GO:0061347 |
2 |
0.022
|
|
|
|
tube closure
|
GO:0060606 |
91 |
0.022
|
|
|
|
establishment of protein localization to plasma membrane
|
GO:0090002 |
34 |
0.022
|
|
|
|
negative regulation of prostatic bud formation
|
GO:0060686 |
4 |
0.022
|
|
|
|
positive regulation of interleukin 8 secretion
|
GO:2000484 |
1 |
0.022
|
|
|
|
regulation of cytoskeleton organization
|
GO:0051493 |
122 |
0.022
|
|
|
|
hexose biosynthetic process
|
GO:0019319 |
39 |
0.022
|
|
|
|
positive regulation of protein serine threonine kinase activity
|
GO:0071902 |
106 |
0.022
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
157 |
0.022
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
206 |
0.022
|
|
|
|
sensory perception of mechanical stimulus
|
GO:0050954 |
107 |
0.021
|
|
|
|
regulation of chromosome organization
|
GO:0033044 |
83 |
0.021
|
|
|
|
protein localization to nucleus
|
GO:0034504 |
121 |
0.021
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
132 |
0.021
|
|
|
|
platelet aggregation
|
GO:0070527 |
20 |
0.021
|
|
|
|
kidney rudiment formation
|
GO:0072003 |
3 |
0.021
|
|
|
|
metal ion homeostasis
|
GO:0055065 |
189 |
0.021
|
|
|
|
regulation of nitrogen cycle metabolic process
|
GO:1903314 |
1 |
0.021
|
|
|
|
exocytosis
|
GO:0006887 |
121 |
0.021
|
|
|
|
protein methylation
|
GO:0006479 |
81 |
0.021
|
|
|
|
extracellular structure organization
|
GO:0043062 |
148 |
0.021
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
73 |
0.021
|
|
|
|
regulation of antimicrobial peptide biosynthetic process
|
GO:0002805 |
1 |
0.021
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
183 |
0.021
|
|
|
|
hemostasis
|
GO:0007599 |
78 |
0.021
|
|
|
|
blood circulation
|
GO:0008015 |
195 |
0.021
|
|
|
|
actomyosin structure organization
|
GO:0031032 |
56 |
0.021
|
|
|
|
response to lipopolysaccharide
|
GO:0032496 |
128 |
0.021
|
|
|
|
protein ubiquitination
|
GO:0016567 |
171 |
0.021
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
232 |
0.021
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
217 |
0.021
|
|
|
|
mesonephros development
|
GO:0001823 |
97 |
0.021
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
142 |
0.021
|
|
|
|
retina development in camera type eye
|
GO:0060041 |
119 |
0.021
|
|
|
|
regulation of ion transport
|
GO:0043269 |
215 |
0.021
|
|
|
|
regulation of actin filament based process
|
GO:0032970 |
99 |
0.021
|
|
|
|
regulation of cellular catabolic process
|
GO:0031329 |
242 |
0.021
|
|
|
|
organelle assembly
|
GO:0070925 |
177 |
0.021
|
|
|
|
negative regulation of secretion
|
GO:0051048 |
61 |
0.021
|
|
|
|
posttranscriptional regulation of gene expression
|
GO:0010608 |
155 |
0.021
|
|
|
|
regulation of nucleotide biosynthetic process
|
GO:0030808 |
34 |
0.021
|
|
|
|
regulation of peptidyl tyrosine phosphorylation
|
GO:0050730 |
93 |
0.021
|
|
|
|
cell substrate adhesion
|
GO:0031589 |
130 |
0.021
|
|
|
|
satellite cell activation involved in skeletal muscle regeneration
|
GO:0014901 |
3 |
0.021
|
|
|
|
positive regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045899 |
2 |
0.021
|
|
|
|
cellular response to cadmium ion
|
GO:0071276 |
3 |
0.021
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
207 |
0.021
|
|
|
|
natural killer cell proliferation
|
GO:0001787 |
3 |
0.020
|
|
|
|
regulation of nucleoside metabolic process
|
GO:0009118 |
130 |
0.020
|
|
|
|
regulation of systemic arterial blood pressure mediated by a chemical signal
|
GO:0003044 |
33 |
0.020
|
|
|
|
peptide metabolic process
|
GO:0006518 |
46 |
0.020
|
|
|
|
central nervous system vasculogenesis
|
GO:0022009 |
3 |
0.020
|
|
|
|
regulation of rna polymerase ii transcriptional preinitiation complex assembly
|
GO:0045898 |
2 |
0.020
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
62 |
0.020
|
|
|
|
mesonephric tubule formation
|
GO:0072172 |
11 |
0.020
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
1 |
0.020
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
156 |
0.020
|
|
|
|
actin filament organization
|
GO:0007015 |
113 |
0.020
|
|
|
|
response to light stimulus
|
GO:0009416 |
135 |
0.020
|
|
|
|
developmental growth involved in morphogenesis
|
GO:0060560 |
138 |
0.020
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
65 |
0.020
|
|
|
|
positive regulation of cysteine type endopeptidase activity
|
GO:2001056 |
39 |
0.020
|
|
|
|
biomineral tissue development
|
GO:0031214 |
64 |
0.020
|
|
|
|
nephron development
|
GO:0072006 |
109 |
0.020
|
|
|
|
regulation of cd4 positive alpha beta t cell differentiation
|
GO:0043370 |
21 |
0.020
|
|
|
|
regulation of interleukin 8 secretion
|
GO:2000482 |
2 |
0.020
|
|
|
|
circulatory system process
|
GO:0003013 |
197 |
0.020
|
|
|
|
positive regulation of peptidyl tyrosine phosphorylation
|
GO:0050731 |
61 |
0.019
|
|
|
|
sensory perception of taste
|
GO:0050909 |
18 |
0.019
|
|
|
|
activation of meiosis
|
GO:0090427 |
4 |
0.019
|
|
|
|
single fertilization
|
GO:0007338 |
82 |
0.019
|
|
|
|
cellular ion homeostasis
|
GO:0006873 |
165 |
0.019
|
|
|
|
regulation of chromatin modification
|
GO:1903308 |
57 |
0.019
|
|
|
|
ureter maturation
|
GO:0035799 |
4 |
0.019
|
|
